IQVIA and Veeva extend their partnership, expanding sponsor access to Veeva's clinical trial and data management technology.
Pharma executive Tim Tallent explains why drugmakers want more transparency in the 340B program amid rising contract pharmacy ...
Since 1987, October in the UK has been celebrated as Black History Month, a time to instill pride and reflect on those who ...
Germany’s Merck has agreed to acquire London-based Silence Therapeutics in an all-cash deal, adding a late-stage rare blood ...
Labcorp acquires BioReference Health assets from OPKO for $722 million, expanding reach of its FDA-approved 4Kscore prostate ...
Estuary Biotherapeutics launches with $103 million to take gene therapies for kidney disease into the clinic. The financing ...
The clinical-stage biotech has closed an oversubscribed Series D financing round in a bid to meeting its mission to stop ...
Biopharma finance leaders detail how they build and refine gross-to-net models amid shrinking margins across biopharma ...
AstraZeneca pays $40 million upfront to put insitro's AI platform to work on metabolic dysfunction-associated steatohepatitis ...
Zealand Pharma has signed a multi-target collaboration with Generate Biomedicines to design protein therapeutics for obesity ...
The regulatory professional then does what only they can do; apply scientific and legal judgment, validate the AI's reasoning ...
Sponsors trialing drugs in the European Union (EU) will be able to continue seeking input from the European Medicines Agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results